Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Assessing Guadalupe Fur Seal Health and Ecology
A multidisciplinary team of researchers will assess the health of Guadalupe fur seal pups and adults by...
Bridging International Borders to Fight Re-emerging Plague in Madagascar
The Plague is considered one of the most successful infectious agents in history and at one point killed...
Do Pacific Northwest marine mammals carry antibiotic-resistant bacteria from land animals?
Antibiotic resistance, a global concern, is a significant health issue of animals and humans. Resistant...